Abstract:Background Diabetic kidney disease (DKD) is the leading cause of death in people with type 2 diabetes mellitus (T2DM). The main objective of this study is to find the potential biomarkers for DKD. Materials and Methods Two datasets ( GSE86300 and GSE184836 ) retrieved from Gene Expression Omnibus (GEO) database were used, combined with our RNA sequencing (RNA-seq) results of DKD mice (C57 BLKS-32w db/db) and non-diabetic (db/m) mice for further analysis. After processing the expression matrix of the three sets of data using R software “Limma”, differential expression analysis was performed. The significantly differentially expressed genes (DEGs) (—logFC— > 1, p -value < 0.05) were visualized by heatmaps and volcano plots respectively. Next, the co-expression genes expressed in the three groups of DEGs were obtained by constructing a Venn diagram. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were further analyzed the related functions and enrichment pathways of these co-expression genes. Then, qRT-PCR was used to verify the expression levels of co-expression genes in the kidney of DKD and control mice. Finally, protein-protein interaction network (PPI), GO, KEGG analysis and Pearson correlation test were performed on the experimentally validated genes, in order to clarify the possible mechanism of them in DKD. Results Our RNA-seq results identified a total of 125 DEGs, including 59 up-regulated and 66 down-regulated DEGs. At the same time, 183 up-regulated and 153 down-regulated DEGs were obtained in GEO database GSE86300 , and 76 up-regulated and 117 down-regulated DEGs were obtained in GSE184836 . Venn diagram showed that 13 co-expression DEGs among the three groups of DEGs. GO analysis showed that biological processes (BP) were mainly enriched inresponse to stilbenoid, response to fatty acid, response to nutrient, positive regulation of macrophage derived foam cell differentiation, triglyceride metabolic process. KEGG pathway analysis showed that the three major enriched pathways were cholesterol metabolism, drug metabolism–cytochrome P450, PPAR signaling pathway. After qRT-PCR validation, we obtained 11 genes that were significant differentially expressed in the kidney tissues of DKD mice compared with control mice. (The mRNA expression levels of Aacs, Cpe, Cd36, Slc22a7, Slc1a4, Lpl, Cyp7b1, Akr1c14 and Apoh were declined, whereas Abcc4 and Gsta2 were elevated). Conclusion Our study, based on RNA-seq results, GEO databases and qRT-PCR, identified 11 significant dysregulated DEGs, which play an important role in lipid metabolism and the PPAR signaling pathway, which provide novel targets for diagnosis and treatment of DKD.

Predictive Metabolic Signatures for the Occurrence and Development of Diabetic Nephropathy and the Intervention of Ginkgo Biloba Leaves Extract Based on Gas or Liquid Chromatography with Mass Spectrometry

Metabolomic Study of the Protective Effect of Gandi Capsule for Diabetic Nephropathy

Serum and Urinary Metabolomic Analysis in Patients with Diabetic Nephropathy

Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy

¹H-Nmr-based Metabonomic Analysis of Metabolic Profiling in Diabetic Nephropathy Rats Induced by Streptozotocin.

Insights into Predicting Diabetic Nephropathy Using Urinary Biomarkers.

Analysis of plasma free amino acids in diabetic rat and the intervention of Ginkgo biloba leaves extract using hydrophilic interaction liquid chromatography coupled with tandem mass-spectrometry

Dang-Gui-Bu-Xue decoction against diabetic nephropathy via modulating the carbonyl compounds metabolic profile and AGEs/RAGE pathway

Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy

Metabolomics Insights into Diabetes Nephropathy and Protective Effects of Radix Scutellariae on Rats Using Ultra-High Performance Liquid Chromatography Coupled with Quadrupole Time-Of- Flight Mass Spectrometry

Screening for Potential Bioactive Components in Ginkgo biloba Extract by the Rat Renal Tubular Epithelial Cell Extraction and LC-MS/MS

To Develop Biomarkers for Diabetic Nephropathy Based on Genes Related to Fibrosis and Propionate Metabolism and Their Functional Validation

Identification of Key Candidate Genes and Chemical Perturbagens in Diabetic Kidney Disease Using Integrated Bioinformatics Analysis

Progress in the Study of Diabetic Nephropathy Markers

Bioinformatics to Identify Biomarkers of Diabetic Nephropathy Based on Sphingolipid Metabolism and Their Molecular Mechanisms.

Gc/Tofms Analysis of Metabolites in Serum and Urine Reveals Metabolic Perturbation of Tca Cycle in Db/Db Mice Involved in Diabetic Nephropathy

Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice

Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy

Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus

Ginkgo Biloba Leaf Extract Prevents Diabetic Nephropathy Through the Suppression of Tissue Transglutaminase

Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis.